患者对可卡因使用障碍的当前和潜在疗法和临床试验方法的看法
Suzanne Maahs1, Denise Leclair2, Baltazar Gomez-Mancilla3,4
1Novartis Biomedical Research, Cambridge, MA, United States.
Frontiers in psychiatry
|March 15, 2024
概括
患有可卡因使用障碍 (CUD) 的人和他们的支持者希望安全,易于获得的疗法来管理渴望和戒断. 这项研究的见解将指导开发用于CUD治疗的有效临床试验.
科学领域:
- 成 药物 药物 药物 药物
- 临床心理学 临床心理学
- 公共卫生 公共卫生
背景情况:
- 可卡因使用障碍 (CUD) 是一种严重的疾病,其特点是持续使用可卡因,尽管有负面的生活后果.
- 了解患者和支持者的观点对于改善CUD治疗和临床试验设计至关重要.
研究的目的:
- 探索当前CUD患者,缓解期患者及其支持者对现有和未来CUD治疗的看法.
- 为设计更有效和以患者为中心的CUD临床试验收集见解.
主要方法:
- 使用在线公告板 (OBB) 为CUD缓解患者及其支持者进行定性研究.
- 虚拟聚焦小组与正在经历CUD的个人进行了虚拟聚焦小组.
- 参与者从美国和国际上招募到缓解小组.
主要成果:
- 目前患有CUD的个人提到耻辱感,隐私问题和害怕被贴上寻求药物的标签是治疗的障碍.
- 治疗的常见障碍包括时间限制,成本和缺乏隐私.
- 参与者表示需要安全的疗法来缓解渴望和戒断症状.
- 确定了七个关键的临床试验结果,重点关注长期禁欲和渴望控制.
结论:
- 这些发现凸显了对有效,安全和易于获得的CUD疗法的需求.
- 与参与者建立信任对于成功招募未来临床试验至关重要.
- 这项研究可以为设计更相关,更有影响力的CUD临床试验提供信息.
相关概念视频
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Treatment Strategies for Psychological Disorders
123
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
123
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Abuse and Addiction: Pharmacological Phenomena
469
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
469
Psychosis: Goals of Pharmacotherapy
127
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
127
Operant Conditioning Intervention
56
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
56


